A Gold Nanoparticle-Based Microfluidic Protein Chip for Tumor Markers
A cancer protein chip has been developed incorporating with signal amplification technology based on gold nanoparticles (AuNPs) and microfluidic technology. The chip was a reversed phase one that deposited the target proteins directly onto chip surface. At first, a tumor marker protein, carcinoma embryonic antigen (CEA), was captured on the chip with the help of first layer microfluidic channel. Then, monoclonal antibody was reacted with the CEA through the second layer microfluidic channel at upright direction against the first layer. In the end, AuNPs labeled secondary antibody and silver enhancement regent were added to creating positive or negative signals in crossed areas, depending on the amounts of tumor marker protein. Using the protein chip based on nanotechnology, we could detect CEA at a wide range of concentration (5–50000 ng/mL) and also had high sensitivity (LOD < 1 pM). Because of its quick detection procedure and no need for high-cost instruments, the protein chip showed potential use for point-of-care (POC) diagnostics.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: February 1, 2009
More about this publication?
- Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites